Problem behaviours and psychotropic medication use in intellectual disability: a multinational cross-sectional survey.
Benjamin I PerryS E CoorayJ MendisK PurandareA WijeratneS ManjubhashiniM DasariF EsanI GunaratnaR A NaseemS HoareV ChesterA RoyJ DevapriamR AlexanderH F KwokPublished in: Journal of intellectual disability research : JIDR (2019)
We found evidence of prevalent potential 'off-label' use for psychotropic medication, which may be due to PBs. We also found evidence of potential diagnostic-overshadowing, where symptoms of psychiatric co-morbidity may have been attributed to PBs. Our findings provide renewed importance, across borders and health systems, for clinicians to consider a holistic approach to treating PBs, and attempting to best understand the precipitants and predisposing factors before psychotropic prescribing.